GE HealthCare Events Center

Cerianna™

Request info

Seeing deeper into recurrent or metastatic breast cancer

Learn about the clinical efficacy and clinical applications for Cerianna.

The Clinical Unmet Need

Learn about the discordance of estrogen-receptor status and how may impact clinical decisions

IMPACT Study Summary

The objective of this study is to determine the clinical validity of FES PET/CT in the MBC setting by evaluating the diagnostic accuracy of this imaging modality for predicting ER status determined by IHC assay of the biopsied metastasis, which included bone metastases.

ACKNOWLEDGEMENTS

GE HealthCare Events Center

Product availability

Not all products and solutions, shown on the GE HealthCare Events Center, may be available in your country. Please contact a GE HealthCare representative to confirm availability.

Information We Collect

We want to be transparent about the data we and our partners collect and how we use it, so you can best exercise control over your personal data. For more information, please see our Privacy Policy.

We use the following partners to better improve your overall web browsing experience. They use cookies and other mechanisms to connect you with your social networks and tailor advertising to better match your interests. You can elect to opt-out of this information collection by unticking the boxes below.